𝔖 Bobbio Scriptorium
✦   LIBER   ✦

568Phase 2 protocol with docetaxel plus prednisone in patients with hormone refractory prostate cancer

✍ Scribed by F.M. Calais da Silva; F.E. Calais da Silva

Book ID
118646697
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
194 KB
Volume
4
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 2 study of carboplatin plus doce
A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel
✍ Robert W. Ross; Tomasz M. Beer; Susanna Jacobus; Glenn J. Bubley; Mary-Ellen Tap 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND. Prostate cancer is the second leading cause of cancer mortality among men in the U.S. To the authors' knowledge, there is no proven, effective, second‐line therapy for docetaxel‐refractory disease. Recent data suggest that platinum salts may be effective when combined wi